Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ENDP [NASD]
Endo Pharmaceuticals Holdings Inc.
Index- P/E- EPS (ttm)-4.73 Insider Own0.60% Shs Outstand151.77M Perf Week8.37%
Market Cap9.34B Forward P/E15.95 EPS next Y3.86 Insider Trans19.25% Shs Float147.76M Perf Month-13.94%
Income-535.50M PEG- EPS next Q0.83 Inst Own92.30% Short Float6.78% Perf Quarter-10.61%
Sales2.62B P/S3.57 EPS this Y21.20% Inst Trans0.32% Short Ratio3.26 Perf Half Y37.84%
Book/sh4.64 P/B13.26 EPS next Y8.52% ROA-9.20% Target Price70.83 Perf Year70.11%
Cash/sh3.47 P/C17.73 EPS next 5Y8.50% ROE-57.90% 52W Range32.66 - 82.16 Perf YTD-8.79%
Dividend- P/FCF48.92 EPS past 5Y-33.80% ROI-8.50% 52W High-24.66% Beta1.18
Dividend %- Quick Ratio1.50 Sales past 5Y15.70% Gross Margin60.30% 52W Low89.53% ATR3.23
Employees3371 Current Ratio1.70 Sales Q/Q226.70% Oper. Margin22.40% RSI (14)42.62 Volatility5.52% 5.51%
OptionableYes Debt/Eq7.11 EPS Q/Q25.50% Profit Margin-22.70% Rel Volume0.52 Prev Close61.53
ShortableYes LT Debt/Eq6.32 EarningsMay 01 BMO Payout- Avg Volume3.07M Price61.90
Recom2.30 SMA20-1.15% SMA50-11.08% SMA2009.44% Volume1,265,459 Change0.60%
04-Mar-14Reiterated FBR Capital Mkt Perform $52 → $82
03-Mar-14Reiterated UBS Buy $75 → $90
06-Nov-13Upgrade Needham Underperform → Hold
06-Nov-13Reiterated Stifel Buy $40 → $60
30-Oct-13Initiated FBR Capital Mkt Perform $40
20-Sep-13Reiterated UBS Buy $43 → $50
21-Jun-13Resumed Oppenheimer Perform
06-Jun-13Reiterated UBS Buy $39 → $41
06-Jun-13Reiterated Stifel Buy $36 → $40
06-Jun-13Downgrade Cantor Fitzgerald Hold → Sell $36 → $30
13-May-13Reiterated Stifel Buy $42 → $36
08-May-13Reiterated RBC Capital Mkts Underperform $28 → $29
17-Apr-13Reiterated Stifel Buy $38 → $42
10-Apr-13Downgrade Standpoint Research Buy → Hold
31-Jan-13Reiterated Cantor Fitzgerald Hold $26 → $34
31-Jan-13Downgrade Oppenheimer Outperform → Perform
04-Jan-13Reiterated UBS Buy $42 → $40
04-Jan-13Reiterated Stifel Nicolaus Buy $40 → $38
04-Jan-13Reiterated RBC Capital Mkts Sector Perform $29 → $25
17-Dec-12Reiterated Cantor Fitzgerald Hold $28 → $26
22-Apr-14 02:04PM  [video] Next big pharma target at CNBC
01:44PM  [video] New age of shareholder activism at CNBC
17-Apr-14 08:00AM  Endo Health Solutions Inc. Announces Receipt of Requisite Tenders and Consents in the Exchange Offers and Consent Solicitations Relating to its 7% Senior Notes due 2019, 7.00% Senior Notes due 2020 and 7ΒΌ% Senior Notes due 2022 PR Newswire
06:45AM  Pullback brings bulls back to Endo optionMONSTER
16-Apr-14 09:22AM  Wednesdays Top Health Care Stories: Zogenix, Endo, and Teva at Motley Fool
08:09AM  [$$] FDA Warns Endo Unit Over Minnesota Facility at The Wall Street Journal
15-Apr-14 04:00PM  Endo to Announce First Quarter 2014 Financial Results on May 1, 2014 PR Newswire
10:22AM  Albany Molecular Aspires To Grow Revenue Five-Fold In As Many Years at Seeking Alpha
14-Apr-14 04:42PM  Endo International (ENDP) Shares Cross Below 200 DMA at TheStreet
10:40AM  Mylan to Settle with Endo on Frova Zacks
08:00AM  Endo Health Solutions Inc. Amends Exchange Offers and Consent Solicitations for its 7% Senior Notes due 2019, 7.00% Senior Notes due 2020 and 7 1/4% Senior Notes due 2022 PR Newswire
11-Apr-14 08:00AM  Endo Health Solutions Inc. Announces Extension of Consent Date and Expiration Date in Exchange Offers and Consent Solicitations for its 7% Senior Notes due 2019, 7.00% Senior Notes due 2020 and 7-1/4% Senior Notes due 2022 PR Newswire
10-Apr-14 08:00AM  Ampio Pharmaceuticals' Vyrix Enters into an Agreement with Paladin Labs for Exclusive Rights to Zertane in Canada and Other Territories to Broaden its International Footprint PR Newswire
09-Apr-14 07:00AM  Louis Van Amstel, Former Dancing with the Stars Professional, Joins "Making Your Move" Campaign to Raise Awareness of Osteoarthritis PR Newswire
08-Apr-14 08:00AM  Endo Health Solutions Inc. Amends Exchange Offers and Consent Solicitations for its 7% Senior Notes due 2019, 7.00% Senior Notes due 2020 and 7 1/4% Senior Notes due 2022 PR Newswire
04-Apr-14 05:26PM  BioDelivery Sciences' Clonidine in Phase III Study Zacks
12:27PM  Mylan Rejected In Bid To Acquire Sweden's Meda at Investor's Business Daily
28-Mar-14 10:30AM  BioDelivery Sciences and Quintiles Sign Deal for Bunavail Zacks
12:25AM  Endo International plc Announces Endo Health Solutions Inc. Will Commence Exchange Offers PR Newswire
26-Mar-14 09:00AM  Millennium Management increases its stake in NextEra Energy Market Realist
08:45AM  J.P. Morgan Says Buy Specialty and Big Pharmaceuticals Now at 24/7 Wall St.
25-Mar-14 05:00PM  Israel Englanders Millennium Management ups its stake in Perrigo Market Realist
01:00PM  Millennium Management buys a new position in SunTrust Banks Market Realist
09:00AM  Millennium Management buys a stake in Crown Holdings Market Realist
24-Mar-14 02:57PM  Millennium Managements 4Q13 positions in Crown Holdings and more Market Realist
21-Mar-14 09:52AM  2013 was the Year of the Biotech Index, Will this Year See a Big Return from Medical Device Stocks? Wall Street Transcript
19-Mar-14 08:06AM  The Zacks Analyst Blog Highlights: Oracle, Microsoft, IBM, BioDelivery Sciences International and Endo Zacks
18-Mar-14 04:00PM  Pipeline Update from BioDelivery Sciences Zacks
10:44AM  Auxilium rises after analyst calls 'ideal' takeover target at theflyonthewall.com
10:00AM  Endo Health Solutions Inc. [ENDP] to Ring The NASDAQ Stock Market Opening Bell GlobeNewswire
13-Mar-14 01:04PM  ENDO HEALTH SOLUTIONS INC. Financials EDGAR Online Financials
12-Mar-14 02:47PM  Cash Abroad Rises $206 Billion as Apple to IBM Avoid Tax Optionetics
02:47PM  Cash Abroad Rises $206 Billion as Apple to IBM Avoid Tax Bloomberg
02:47PM  Cash Abroad Rises $206 Billion as Apple to IBM Avoid Tax
10:42AM  Cash Abroad Rises $206 Billion as Apple to IBM Avoid Tax Bloomberg
05:00AM  Cash Abroad Rises $206 Billion as Apple to IBM Avoid Tax Optionetics
05:00AM  Cash Abroad Rises $206 Billion as Apple to IBM Avoid Tax Bloomberg
05:00AM  Cash Abroad Rises $206 Billion as Apple to IBM Avoid Tax at Bloomberg
05:00AM  Cash Abroad Rises $206 Billion as Apple to IBM Avoid Tax
10-Mar-14 11:00AM  Update on Endo's Product Portfolio Zacks
11:00AM  Update on Endo's Product Portfolio
08:25AM  Cantor Fitzgerald Says Sell Twitter and Five Other Stocks Now at 24/7 Wall St.
08:25AM  Cantor Fitzgerald Says Sell Twitter and Five Other Stocks Now
07-Mar-14 01:04PM  ENDO INTERNATIONAL PLC Financials EDGAR Online Financials
07:30AM  Endo Announces Appointment of Dr. Susan Hall as New Chief Scientific Officer and Global Head of R&D and Quality PR Newswire
07:30AM  Endo Announces Appointment of Dr. Susan Hall as New Chief Scientific Officer and Global Head of R&D and Quality CNW Group
06-Mar-14 04:00PM  Why did Lone Pine Capital decide to move out of Equinix? Market Realist
04:00PM  Why did Lone Pine Capital decide to move out of Equinix?
12:00PM  Must know: Why Lone Pine Capital exited its position in eBay Market Realist
12:00PM  Must know: Why Lone Pine Capital exited its position in eBay
08:00AM  Why Lone Pine bought a new position in Endo Health Solutions Market Realist
08:00AM  Why Lone Pine bought a new position in Endo Health Solutions
07:12AM  Endo Health's Aveed testosterone injection approved by FDA theflyonthewall.com
07:00AM  U.S. FDA Approves AVEED (Testosterone Undecanoate) Injectable Testosterone Replacement Therapy For Men Living With Hypogonadism, Or Low-T PR Newswire
05-Mar-14 05:33PM  Recro Pharma IPO Could Be More Painful Than Expected at Seeking Alpha
05:17PM  This $23 Billion Long-Term Winner Has Been Buying Health Care and Lumber at Motley Fool
04:00PM  Lone Pine Capital opens a new position in Mcgraw Hill Financial Market Realist
12:00PM  Why did Lone Pine Capital buy a stake in SBA Communications? Market Realist
08:00AM  Why did Lone Pine open a position in IntercontinentalExchange? Market Realist
04-Mar-14 05:47PM  Why did Lone Pine Capital initiate a new position in Microsoft? Market Realist
01:46PM  Must-know update: Lone Pine Capitals positions in 4Q 2013 Market Realist
03-Mar-14 12:27PM  Q4 Earnings Decline Y/Y at Endo, Weak Outlook Zacks
11:37AM  Endo International: More M&A Please at Barrons.com
06:04AM  ENDO HEALTH SOLUTIONS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition EDGAR Online
01-Mar-14 12:28PM  Endo Health Solutions' CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
28-Feb-14 11:06AM  Endo completes acquisition of Paladin Labs theflyonthewall.com
11:02AM  Endo Completes Acquisition of Paladin Labs PR Newswire
09:08AM  ENDO HEALTH SOLUTIONS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online
08:30AM  Endo Health Solutions Inc. Earnings Call scheduled for 8:30 am ET today CCBN
08:25AM  Endo Health Solutions Inc. Discusses Q4 2013 Results (Webcast) at Seeking Alpha
08:20AM  Endo Health Solutions Inc. Earnings Call scheduled for 8:30 am ET today CCBN
07:34AM  Endo Health Solutions Inc. Earnings Call scheduled for 8:30 am ET today CCBN
07:07AM  Q4 2013 Endo Health Solutions Inc. Earnings Release - Before Market Open CCBN
06:00AM  Endo Reports Fourth Quarter And Full Year 2013 Financial Results PR Newswire
27-Feb-14 05:44PM  Endo Health Solutions Announces Departure Of Chief Scientific Officer PR Newswire
26-Feb-14 01:16PM  ENDO HEALTH SOLUTIONS INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events, Fin EDGAR Online
12:30PM  Endo Announces Shareholder Approval of its Acquisition of Paladin Labs PR Newswire
06:30AM  Slap on the wrist for pushing pain killers at MarketWatch
25-Feb-14 04:16AM  Bullish 3-way bet on Endo Health optionMONSTER
24-Feb-14 10:30AM  Legal Settlement at Endo on Lidoderm Zacks
21-Feb-14 03:15PM  Endo Health to pay $192.7M in gov't settlement AP
02:03PM  Endo to Pay $193 Million in Lidoderm Marketing Probe at Bloomberg
01:06PM  Endo to pay $193 million over Lidoderm marketing Reuters
12:49PM  Endo Announces Resolution of Government Investigation PR Newswire
09:10AM  Endo Health price target raised to $86 from $75 at Goldman at theflyonthewall.com
20-Feb-14 02:00PM  Endo to Announce Fourth Quarter 2013 Financial Results on February 28, 2014 PR Newswire
11:21AM  Actavis Q4 Beats Street; Guidance Affirmed For Now at Investor's Business Daily
19-Feb-14 07:31AM  ENDO HEALTH SOLUTIONS INC. Files SEC form 8-K, Material Impairments, Other Events, Financial Statements and Exhibits EDGAR Online
07:30AM  Endo Announces 2013 Non-Cash Charges PR Newswire
18-Feb-14 09:30AM  Straightening Out Auxilium Pharma's Value at Seeking Alpha +5.83%
08:30AM  Endo Announces South African Competition Act Compliance and Approval Under the Investment Canada Act in Connection with Its Proposed Acquisition of Paladin Labs PR Newswire
08-Feb-14 01:58AM  [$$] 13D Filings at Barrons.com
04-Feb-14 05:45PM  Endo Closes Boca Pharmacal Acquisition Zacks
09:00AM  What to Watch at DexCom, Smith & Nephew, and Endo Health Solutions This Morning at Motley Fool
03-Feb-14 04:00PM  Endo Completes Divestiture Of HealthTronics PR Newswire
08:00AM  Endo Completes Acquisition of Specialty Generics Company Boca Pharmacal PR Newswire
30-Jan-14 05:02PM  Endo Health Scores Legal Victory Zacks
05:02PM  Endo Health Scores Legal Victory
29-Jan-14 04:30PM  Endo Confirms Court Upholds FROVA Patent PR Newswire
04:30PM  Endo Confirms Court Upholds FROVA Patent
Endo International plc, a specialty healthcare company, develops, manufactures, markets, and distributes branded pharmaceutical and generic products, and medical devices worldwide. It provides branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar, and Fortesta Gel to treat and manage pain and conditions in urology, endocrinology, and oncology. The company also offers non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets; and pharmaceutical products in the areas of ADHD, pain, urology, and allergy. In addition, it provides various medical devices comprising AMS 700 MS series, AMS 800 artificial urinary sphincters, GreenLight XPS laser systems, Elevate anterior and posterior pelvic floor repair systems, and Monarc subfascial hammock products in the areas of men's and women's health, and prostate health. The company's products also include Aveed, an injectable testosterone preparation to treat male hypogonadism; and BEMA Buprenorphine, a transmucosal form of buprenorphine in Phase III trials for treating moderate to severe chronic pain. It serves pharmacy chains directly; and hospitals, governmental agencies, pharmacies, and physicians through wholesale drug distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MANOGUE CAROLINE BExec. V.P., CLO & SecyAug 26Option Exercise28.61130,0003,719,300192,014Aug 27 05:18 PM
MANOGUE CAROLINE BExec. V.P., CLO & SecyAug 26Sale39.40145,5925,736,32546,422Aug 27 05:18 PM
KIMMEL ROGER HDirectorAug 08Buy36.505,478199,94751,914Aug 09 05:13 PM
Gergel Ivan P.EVP, R&D and CSOApr 24Option Exercise20.74105,1902,181,47194,241Apr 26 04:02 PM
Gergel Ivan P.EVP, R&D and CSOApr 24Sale36.45138,2255,038,9110Apr 26 04:02 PM